RxDoctor Payments Data

William Aderhold

Physician Assistant · Erwin, TNNPI 1003975707

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by AbbVie at 36.7% of the total. Reporting peaked in 2023 at $17,915 and has fallen 90.4% since, to $1,715 in 2025. Among physician assistant clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,286in general payments, 2019–2025

Across 658 payments — averaging $50.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$12K
  • Amgen$10K
  • Novo Nordisk$3K
  • Lilly USA, LLC$1K
  • AstraZeneca$849
  • Bayer$704
  • plus $5K from 35 others

What the payments were for

  • Consulting fees$1,5905%
  • Speaking & faculty fees$18,34455%
  • Travel & lodging$5752%
  • Food & beverage$12,74338%
  • Education$340%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,286 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide59$65,642
JardianceEmpagliflozin57$51,172
OzempicSemaglutide34$46,155
EntrestoSacubitril/Valsartan50$44,287
EliquisApixaban51$39,338
VascepaIcosapent Ethyl89$38,511
FarxigaDapagliflozin Propanediol40$36,410
TrulicityDulaglutide31$34,624
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$28,868
VraylarCariprazine Hcl16$23,922
KerendiaFinerenone20$17,746
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$15,256
Repatha SureclickEvolocumab20$13,523
Tresiba Flextouch U-200Insulin Degludec12$8,653
GlyxambiEmpagliflozin/Linagliptin12$7,359

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,198$100,26690 claims
Boehringer IngelheimJardiance, Glyxambi$400$58,53069 claims
Novo NordiskOzempic$3,436$46,15534 claims
NovartisEntresto$328$44,28750 claims
PfizerEliquis$113$39,33851 claims
AstraZenecaFarxiga$849$36,41040 claims
GSKTrelegy Ellipta$599$28,86826 claims
AbbVieVraylar$12,200$23,92216 claims
BayerKerendia$704$17,74620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Erwin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →